Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Surveillance for Viral Hepatitis – United States, 2013

Entire report in a printable format [PDF – 1,441 KB – 65 pages]Please note: An erratum has been published for the summary in this PDF. To view the erratum, please click here

Contents

  Hepatitis A

  Hepatitis B

  Hepatitis C

  Discussion

Hepatitis A virus

Index

PAGE
DESCRIPTION
Table 2.1 Reported cases of hepatitis A, nationally and by state ― United States, 2009-2013
Table 2.2 Clinical characteristics of reported cases of hepatitis A ― United States, 2013
Table 2.3 Number and rate of hepatitis A-related deaths, by demographic characteristics and year — United States, 2009–2013
Figure 2.1 Reported number of acute hepatitis A cases — United States, 2000-2013
Figure 2.2 Incidence of hepatitis A, by age group — United States, 2000-2013
Figure 2.3 Incidence of hepatitis A, by sex — United States, 2000-2013
Figure 2.4 Incidence of hepatitis A, by race/ethnicity — United States, 2000-2013
Figure 2.5 Availability of information on risk exposures/behaviors associated with hepatitis A – United States, 2013
Figure 2.6a Hepatitis A reports, by risk behavior — United States, 2013
Figure 2.6b Hepatitis A reports, by risk exposure — United States, 2013
  

Hepatitis A virus

Table 2.1 Reported cases of acute hepatitis A, by state ― United States, 2009–2013

State
2009
2010
2011
2012
2013
Rate* (No.) Rate (No.) Rate (No.) Rate (No.) Rate (No.)
Alabama
0.3
(12)
0.2
(8)
0.2
(8)
0.4
(19)
0.2 (10)
Alaska
0.3
(2)
0.7
(5)
0.6
(4)
0.1
(1)
0.1 (1)
Arizona
1.0
(68)
1.0
(61)
1.2
(77)
1.4
(93)
1.0 (66)
Arkansas
0.4
(12)
0.1
(2)
0.1
(3)
0.3
(8)
0.3 (9)
California
0.7
(273)
0.6
(242)
0.5
(186)
0.5
(209)
0.7 (255)
Colorado
1.0
(52)
0.7
(36)
0.4
(21)
0.5
(28)
1.0 (51)
Connecticut
0.5
(18)
0.8
(29)
0.5
(18)
0.6
(23)
0.5 (19)
Delaware
0.5
(4)
0.8
(7)
0.2
(2)
1
(9)
0.4 (4)
District of Columbia
0.2
(1)
0.2
(1)
U
U
U
U
U (U)
Florida
0.9
(171)
0.7
(139)
0.5
(87)
0.5
(87)
0.6 (115)
Georgia
0.5
(54)
0.4
(40)
0.3
(27)
0.5
(46)
0.4 (36)
Hawaii
0.8
(11)
0.6
(8)
0.6
(8)
0.4
(5)
1.1 (16)
Idaho
0.3
(5)
0.5
(8)
0.4
(6)
0.7
(11)
0.5 (8)
Illinois
1.0
(126)
0.4
(48)
0.6
(73)
0.5
(67)
0.6 (79)
Indiana
0.3
(17)
0.2
(12)
0.4
(24)
0.2
(11)
0.5 (32)
Iowa
1.3
(38)
0.4
(11)
0.3
(8)
0.2
(7)
0.6 (17)
Kansas
0.4
(12)
0.5
(14)
0.1
(4)
0.5
(15)
0.4 (11)
Kentucky
0.3
(12)
0.6
(26)
0.2
(10)
0.6
(25)
0.5 (24)
Louisiana
0.1
(6)
0.2
(11)
0.1
(5)
0.2
(7)
0.3 (14)
Maine
0.1
(1)
0.5
(7)
0.5
(6)
0.7
(9)
0.8 (10)
Maryland
0.8
(47)
0.4
(23)
0.4
(26)
0.5
(28)
0.5 (29)
Massachusetts
1.1
(71)
0.7
(48)
0.6
(39)
0.6
(40)
0.6 (43)
Michigan
0.7
(72)
0.7
(73)
0.7
(70)
1
(100)
0.8 (83)
Minnesota
0.6
(29)
0.7
(37)
0.5
(27)
0.5
(29)
0.6 (32)
Mississippi
0.3
(9)
0.1
(2)
0.2
(7)
0.4
(11)
0.2 (5)
Missouri
0.4
(21)
0.4
(21)
0.2
(13)
0.3
(20)
0.1 (8)
Montana
0.6
(6)
0.4
(4)
0.3
(3)
0.6
(6)
0.6 (6)
Nebraska
1.2
(21)
0.8
(14)
0.3
(5)
0.9
(16)
0.7 (13)
Nevada
0.6
(15)
0.5
(14)
0.2
(5)
0.4
(10)
0.7 (19)
New Hampshire
0.5
(7)
0.2
(2)
0
(0)
0.5
(6)
0.7 (9)
New Jersey
0.8
(71)
0.9
(76)
0.9
(79)
0.7
(60)
0.8 (68)
New Mexico
0.4
(8)
0.2
(5)
0.3
(7)
0.5
(10)
1.0 (20)
New York
0.7
(136)
0.8
(147)
0.6
(113)
0.6
(111)
0.8 (167)
North Carolina
0.4
(41)
0.5
(48)
0.3
(31)
0.3
(34)
0.5 (46)
North Dakota
0.3
(2)
0.6
(4)
0
(0)
0.3
(2)
1.2 (9)
Ohio
0.3
(36)
0.4
(47)
0.3
(39)
0.3
(36)
0.5 (59)
Oklahoma
0.2
(7)
0.2
(6)
0.3
(11)
0.3
(12)
0.4 (14)
Oregon
0.5
(19)
0.4
(17)
0.3
(11)
0.2
(9)
0.7 (29)
Pennsylvania
0.5
(68)
0.4
(53)
0.5
(60)
0.5
(62)
0.4 (53)
Rhode Island
0.9
(9)
0.9
(9)
0.8
(8)
0.3
(3)
0.4 (4)
South Carolina
1.4
(63)
0.6
(26)
0.2
(11)
0.1
(6)
0.3 (14)
South Dakota
0.4
(3)
0.1
(1)
0.2
(2)
0
0
0.5 (4)
Tennessee
0.2
(13)
0.2
(12)
0.4
(23)
0.4
(23)
0.3 (20)
Texas
0.7
(184)
0.6
(139)
0.5
(138)
0.5
(134)
0.4 (109)
Utah
0.3
(7)
0.4
(12)
0.3
(8)
0.1
(4)
0.4 (12)
Vermont
0.3
(2)
0
0
1.0
(6)
0.3
(2)
1.1 (7)
Virginia
0.5
(42)
0.6
(52)
0.4
(30)
0.6
(49)
0.4 (36)
Washington
0.6
(42)
0.3
(21)
0.5
(31)
0.4
(29)
0.6 (45)
West Virginia
0.3
(6)
0.8
(15)
0.4
(8)
0.4
(8)
0.2 (4)
Wisconsin
0.6
(33)
0.4
(23)
0.1
(8)
0.4
(21)
0.6 (37)
Wyoming
0.4
(2)
0.7
(4)
0.4
(2)
0.2
(1)
0.0 (0)
Total
0.6
(1,987)
0.5
(1,670)
0.4
(1,398)
0.5
(1,562)
0.6 (1,781)

*Rate per 100,000 population. 
U=No data available for reporting.
Source: CDC, National Notifiable Diseases Surveillance System.

Table 2.2 Clinical characteristics of reported cases of hepatitis A ― United States, 2013

Clinical characteristic
Availability of valid data† for clinical characteristic
Cases with clinical characteristic§
No.
%
No.
%
Jaundice
1,095 61.5 753 68.8
Hospitalized for hepatitis A
1,081 60.7 519 48.0
Died from hepatitis A
959 53.8 9 0.9

*A total of 1,562 hepatitis A cases were reported during 2012.
†Case reports for which questions regarding clinical characteristics were answered with “yes” or “no.” Reports with any other response were excluded.
§Numbers and percentages represent only those case reports for which data regarding clinical characteristics were available; numbers likely are underestimates.
Source: CDC, National Notifiable Diseases Surveillance System.

Table 2.3 Number and rate of hepatitis A-related deaths, by demographic characteristics and year — United States, 2009–2013

Demographic characterisic
2009
2010
2011
2012
2013
No. Rate No. Rate No. Rate No. Rate No. Rate
  Age Group
(years)
0–34  1 0.00 3 0.00 0 0.00 2 0.00 2 0.00
35–44 1 0.00 7 0.02 1 0.00 5 0.01 2 0.00
45–54 14 0.03 25 0.06 11 0.02 12 0.03 13 0.03
55–64 22 0.06 34 0.09 16 0.04 23 0.06 30 0.08
65–74 12 0.06 10 0.05 12 0.05 17 0.07 19 0.08
≥75 32 0.17 16 0.09 29 0.15 18 0.09 14 0.07
 
Race White§ 68 0.02                
Black 13 0.04                
Non-White, non-Black 1 0.00                
 
  Race/
Ethnicity
White, non-
Hispanic
    65 0.03 44 0.02 51 0.02 63 0.02
Black, non-
Hispanic
    15 0.04 10 0.03 8 0.02 6 0.01
Hispanic     12 0.03 6 0.02 8 0.02 8 0.02
Asian/Pacific
Islander
    2 0.02 8 0.06 7 0.05 3 0.02
American
Indian/Alaskan
Native
    1 0.05 1 0.04 2 0.08 0 0.00
 
Sex Male 50 0.03 73 0.05 37 0.02 46 0.03 50 0.03
Female 32 0.02 22 0.01 32 0.02 31 0.02 30 0.01
 
Overall  82 0.02 95 0.03 69 0.02 77 0.02 80 0.02

* Rates for race, sex, and overall total are age-adjusted per 100,000 U.S. standard population.
†Cause of death is defined as the underlying cause of death or one of the multiple causes of death and is based on the International Classification of Diseases, 10th Revision (ICD-10) codes B15 (hepatitis A).
§ The race category "White" Included white, non-Hispanic and white Hispanic. The race category "Black" included black, non-Hispanic and black Hispanic. The race category "Non-White, non-Black" included all other races.
¶ The race/ethnicity category was added starting in 2010 to incorporate bridged race categories. One death in 2012 is not represented under the race/ethnicity category due to missing race and/or ethnicity data.

Source: CDC. National Vital Statistics System.

Figure 2.1. Reported number of hepatitis A cases – United States, 2000-2013

Downloads of this slide: PDF    PowerPoint
Figure 2.2. Incidence of hepatitis A, by age group – United States, 2000-2013

Downloads of this slide: PDF    PowerPoint
Figure 2.3. Incidence of hepatitis A, by sex – United States, 2000-2013

Downloads of this slide: PDF    PowerPoint
Figure 2.4. Incidence of hepatitis A, by race/ethnicity – United States, 2000-2013

Downloads of this slide: PDF    PowerPoint
Figure 2.5. Availability of information on risk exposures/behaviors associated with hepatitis A – United States, 2013

Downloads of this slide: PDF    PowerPoint
Figure 2.6a. Hepatitis A reports, by risk exposure/behavior – United States, 2013

Downloads of this slide: PDF    PowerPoint
Figure 2.6b. Hepatitis A reports, by risk exposure/behavior – United States, 2013

Downloads of this slide: PDF    PowerPoint

All seven figure slides in PowerPoint 2007 format [PPTX – 820KB]
 

Hepatitis B virus

PAGE
DESCRIPTION
Table 3.1 Reported cases of acute hepatitis B, nationally and by state ― United States, 2009-2013
Table 3.2 Clinical characteristics of reported cases of acute hepatitis B ― United States, 2013
Table 3.3 Number of newly reported chronic hepatitis B case-reports submitted by states, 2013
Table 3.4 Reported cases of chronic hepatitis B, by demographic characteristics and laboratory tests – Enhanced Viral Hepatitis Surveillance Sites, 2013
Table 3.5 Number and rate of hepatitis B-related deaths, by demographic characteristics and year – United States, 2009-2013
Figure 3.1 Reported number of acute hepatitis B cases — United States, 2000-2013
Figure 3.2 Incidence of acute hepatitis B, by age group — United States, 2000-2013
Figure 3.3 Incidence of acute hepatitis B, by sex — United States, 2000-2013
Figure 3.4 Incidence of acute hepatitis B, by race/ethnicity — United States, 2000-2013
Figure 3.5 Availability of information on risk behaviors/exposures associated with acute hepatitis B — United States, 2013
Figure 3.6a Acute hepatitis B reports, by risk behavior — United States, 2013
Figure 3.6b Acute hepatitis B reports, by risk exposure — United States, 2013
  

Hepatitis B virus

Table 3.1 Reported cases of acute hepatitis B, nationally and by state ― United States, 2009-2013

State
2009
2010
2011
2012
2013
Rate* (No.) Rate (No.) Rate (No.) Rate (No.) Rate (No.)
Alabama
1.9
(89)
1.4
(68)
2.5
(119)
1.6
(79)
1.9
(90)
Alaska
0.6
(4)
0.7
(5)
0.4
(3)
0.1
(1)
0.1
(1)
Arizona
0.6
(42)
0.4
(26)
0.2
(14)
0.2
(14)
0.4
(28)
Arkansas
2.2
(65)
2.3
(66)
1.9
(57)
2.5
(74)
1.7
(50)
California
0.7
(258)
0.7
(252)
0.4
(157)
0.4
(136)
0.4
(138)
Colorado
0.5
(27)
0.9
(46)
0.4
(23)
0.5
(24)
0.5
(24)
Connecticut
0.5
(16)
0.6
(22)
0.5
(19)
0.4
(15)
0.2
(8)
Delaware †
U
U
U
U
1.4
(13)
1.2
(11)
1.5
(14)
District of Columbia
1.7
(10)
0.5
(3)
U
U
U
U
U
(U)
Florida
1.6
(299)
1.6
(297)
1.1
(213)
1.3
(247)
1.7
(323)
Georgia
1.5
(144)
1.7
(165)
1.4
(142)
1.1
(109)
1.0
(104)
Hawaii
0.5
(6)
0.4
(6)
0.4
(6)
0.4
(5)
0.3
(4)
Idaho
0.7
(11)
0.4
(6)
0.1
(2)
0.3
(5)
0.8
(13)
Illinois
0.9
(118)
1.1
(135)
0.7
(85)
0.7
(86)
0.7
(94)
Indiana
1.2
(74)
1.2
(75)
1.1
(70)
1.4
(90)
1.5
(101)
Iowa
1.2
(37)
0.5
(15)
0.5
(15)
0.4
(13)
0.4
(11)
Kansas
0.2
(6)
0.4
(11)
0.5
(15)
0.3
(9)
0.4
(11)
Kentucky
2.1
(90)
3.1
(136)
3.5
(151)
4.1
(180)
4.9
(214)
Louisiana
1.6
(73)
1.2
(55)
1.4
(62)
1
(44)
1.8
(82)
Maine
1.1
(15)
1.0
(13)
0.6
(8)
0.7
(9)
0.8
(11)
Maryland
1.3
(72)
1.2
(67)
1.1
(62)
0.9
(52)
0.7
(43)
Massachusetts
0.3
(17)
0.2
(13)
1.0
(67)
1.1
(75)
1.1
(71)
Michigan
1.3
(132)
1.2
(122)
0.9
(91)
0.8
(81)
0.5
(53)
Minnesota
0.7
(38)
0.4
(23)
0.4
(20)
0.3
(17)
0.4
(19)
Mississippi
1.1
(33)
1.1
(33)
1.9
(57)
2.6
(78)
1.8
(55)
Missouri
0.8
(47)
1.1
(67)
1.0
(60)
0.8
(48)
1.0
(61)
Montana
0.1
(1)
0
(0)
0
(0)
0.2
(2)
0.4
(4)
Nebraska
1.2
(22)
0.7
(12)
0.7
(12)
0.5
(10)
0.5
(9)
Nevada
1.3
(34)
1.5
(41)
1.1
(29)
1
(28)
1.0
(29)
New Hampshire
0.5
(6)
0.4
(5)
0.2
(3)
0.3
(4)
0.2
(2)
New Jersey
1.1
(93)
0.9
(77)
0.8
(73)
0.8
(70)
0.7
(65)
New Mexico
0.4
(8)
0.2
(5)
0.5
(10)
0.1
(3)
0.1
(3)
New York
0.7
(129)
0.7
(139)
0.7
(134)
0.6
(113)
0.6
(117)
North Carolina
1.1
(104)
1.2
(113)
1.1
(109)
0.7
(73)
0.8
(75)
North Dakota
0
(0)
0
(0)
0
(0)
0
0
0.0
(0)
Ohio
0.8
(88)
0.8
(95)
0.8
(90)
1.5
(178)
1.9
(225)
Oklahoma
3.3
(122)
3.1
(115)
2.6
(100)
2.1
(79)
1.0
(40)
Oregon
1.2
(44)
1.1
(42)
0.8
(32)
0.6
(25)
0.8
(32)
Pennsylvania
0.8
(106)
0.6
(72)
0.7
(84)
0.5
(63)
0.3
(43)
Rhode Island
U
U
U
U
U
U
U
U
U
(U)
South Carolina
1.2
(56)
1.3
(59)
0.8
(39)
0.8
(37)
1.2
(58)
South Dakota
0.5
(4)
0.2
(2)
0.2
(2)
0.2
(2)
0.6
(5)
Tennessee
2.2
(136)
2.4
(150)
3.0
(192)
3.7
(240)
4.0
(262)
Texas
1.7
(420)
1.6
(394)
0.8
(204)
0.7
(170)
0.5
(142)
Utah
0.2
(5)
0.3
(8)
0.4
(10)
0.5
(13)
0.2
(5)
Vermont
0
(0)
0.3
(2)
0
(0)
0.3
(2)
0.3
(2)
Virginia
1.4
(110)
1.2
(97)
1.0
(84)
1
(84)
0.9
(72)
Washington
0.7
(48)
0.7
(50)
0.5
(35)
0.5
(34)
0.5
(33)
West Virginia
4.6
(84)
4.7
(88)
6.1
(113)
7.6
(141)
10.5
(195)
Wisconsin
0.4
(24)
0.9
(54)
0.3
(17)
0.4
(22)
0.2
(9)
Wyoming
0.7
(4)
0.5
(3)
0
(0)
0
0
U
(U)
Total
1.1
(3,371)
1.1
(3,350)
0.9
(2,890)
0.9
(2,895)
1.0
(3,050)

*Rate per 100,000 population.
† Updated data for Delaware in 2011.
U=No data available for reporting.
Source: CDC, National Notifiable Diseases Surveillance System.

Table 3.2 Clinical characteristics of reported cases of acute hepatitis B ― United States, 2013

Clinical characteristic
Availability of valid data† for clinical characteristic
Cases with clinical characteristic§
No.
%
No.
%
Jaundice
2,149 70.5 1,653 76.9
Hospitalized for hepatitis B
2,125 69.7 1,250 58.8
Died from hepatitis B
2,018 66.2 18 0.9

* A total of 3,050 hepatitis B cases were reported during 2013.
† Case reports for which questions regarding clinical characteristics were answered with “yes” or “no.” Reports with any other response were excluded.
§ Numbers and percentages represent only those case reports for which data regarding clinical characteristics were available; numbers likely are underestimates.
Source: CDC, National Notifiable Diseases Surveillance System.

Table 3.3 Number of newly reported chronic hepatitis B case-reports submitted by states, 2013

Jurisdiction^ No. chronic hepatitis B
case reports submitted
Data Source
Colorado¶ 511 NNDSS
Delaware 126 State-provided
Florida¶ 4,270 NNDSS
Iowa 266 State-provided
Kansas 108 State-provided
Maine¶ 107 State-provided
Michigan¶ 1,130 State-provided
Minnesota¶ 189 NNDSS
Montana¶ 21 State-provided
New Jersey** 303 NNDSS
New Mexico¶ 119 NNDSS
New York
(minus New York City)**
636 State-provided
New York City** 5,857 State-provided
Oregon** 150 State-provided
Pennsylvania¶ 1,512 State-provided
South Carolina†† 448 NNDSS
South Dakota¶ 79 NNDSS
West Virginia¶ 212 State-provided
Total 16,044  

Abbreviation: NNDSS, National Notifiable Diseases Surveillance System
* For case-definition, see
http://wwwn.cdc.gov/nndss/script/ConditionList.aspx?Type=0&Yr=2012
† Reports may not reflect unique cases.
§ Jurisdictions that gave permission to report their number of chronic HBV cases
** Includes confirmed case reports only.
†† Includes confirmed, probable, and suspect case reports.

Table 3.4. Reported cases of chronic hepatitis B, by demographic characteristics and laboratory tests – Enhanced Viral Hepatitis Surveillance Sites, 2013

Category Massa-
chusetts
No. (%)
Michigan
No. (%)
New York
State†
No. (%)
Philadel-
phia
No. (%)
San Francisco
No. (%)
Washing-
ton§
No. (%)
Total
No. (%)
Sex
Female 224
49.1%
207
43.9%
236
36.5%
118
42.1%
339
46.3%
72
42.4%
1,196
43.4%
Male 231
50.7%
264
56.1%
409
63.2%
162
57.9%
387
52.9%
91
53.5%
1,544
56.0%
Unknown/
missing
1
0.2%
0
0.0%
2
0.3%
0
0.0%
6
0.8%
7
4.1%
16
0.6%
Race/ethnicity
American Indian/
Alaskan Native,
non-Hispanic (NH)
0
0.0%
5
1.1%
1
0.2%
0
0.0%
0
0.0%
4
2.4%
10
0.4%
Asian/Pacific
Islander,  NH
177
38.8%
114
24.2%
176
27.2%
98
35.0%
364
49.7%
48
28.2%
977
35.4%
Black,  NH 80
17.5%
98
20.8%
83
12.8%
52
18.6%
9
1.2%
5
2.9%
327
11.9%
White,  NH 46
10.1%
124
26.3%
99
15.3%
14
5.0%
16
2.2%
30
17.6%
329
11.9%
Hispanic 30
6.6%
7
1.5%
29
4.5%
12
4.3%
0
0.0%
5
2.9%
83
3.0%
Other,  NH 29
6.4%
26
5.5%
26
4.0%
9
3.2%
6
0.8%
5
2.9%
101
3.7%
Unknown/
missing
94
20.6%
97
20.6%
233
36.0%
95
33.9%
337
46.0%
73
42.9%
929
33.7%
Age group, years
0-14 7
1.5%
9
1.9%
5
0.8%
3
1.1%
6
0.8%
4
2.4%
34
1.2%
15-24 34
7.5%
31
6.6%
60
9.3%
22
7.9%
49
6.7%
15
8.8%
211
7.7%
25-39 165
36.2%
143
30.4%
240
37.1%
93
33.2%
258
35.2%
48
28.2%
947
34.4%
40-54 141
30.9%
147
31.2%
189
29.2%
101
36.1%
215
29.4%
62
36.5%
855
31.0%
55+ 109
23.9%
141
29.9%
153
23.6%
61
21.8%
204
27.9%
41
24.1%
709
25.7%
Unknown/
missing
0
0.0%
0
0.0%
0
0.0%
0
0.0%
0
0.0%
0
0.0%
0
0.0%
Place of birth
United States 39
8.6%
127
27.0%
12
1.9%
139
49.6%
10
1.4%
U
 
327
12.6%
Outside United States 224
49.1%
121
25.7%
47
7.3%
120
42.9%
67
9.2%
U
 
579
22.4%
Unknown/
missing
193
42.3%
223
47.3%
588
90.9%
21
7.5%
655
89.5%
U
 
1,680
65.0%
Hepatitis B laboratory testing¶
HBV surface antigen + 399
87.5%
269
57.1%
541
83.6%
233
83.2%
654
89.3%
81
47.6%
2,177
79.0%
[IgM anti-HBc] – 77
16.9%
25
5.3%
106
16.4%
0
0.0%
0
0.0%
42
24.7%
250
9.1%
HBV “e” antigen + 155
34.0%
2
0.4%
99
15.3%
64
22.9%
75
10.2%
12
7.1%
407
14.8%
HBV NAT + 281
61.6%
4
0.8%
203
31.4%
228
81.4%
465
63.5%
45
26.5%
1,226
44.5%
Total no. cases  456 471 647 280 732 170 2,756
2013 Estimated
population total**
6,692,824 9,895,622 11,245,290 1,553,165 837,442 5,405,750 35,630,093
Rate per 100,000
population
6.8 4.8 5.8 18.0 87.4 3.1 7.7

* Chronic hepatitis B data from Florida, one of the 7 funded sites, were not included in this table.  Chronic hepatitis B data from all funded sites, including Florida, will be published in an updated table in July.
† Cases and population estimates from New York excluded those who resided in New York City.
§ Cases from Washington excluded Snohomish County, Pierce County, and 90% of King County.
¶ Cases can be reported with more than one laboratory test result. The denominator used to calculate proportions was the total number of cases reported for each site.
** Population estimates for the United States: https://wonder.cdc.gov/bridged-race-population.html. Population estimates from Washington excluded Snohomish and Pierce Counties.
U = No data available for reporting.

Table 3.5. Number and rate of hepatitis B-related deaths, by demographic characteristics and year – United States, 2009-2013

Demographic characteristic
2009
2010
2011
2012
2013
No. Rate No. Rate No. Rate No. Rate No. Rate
Age Group
(years)
0–34 39 0.03 48 0.03 41 0.03 38 0.03 40 0.03
35–44 143 0.34 142 0.35 143 0.35 123 0.30 146 0.36
45–54 469 1.05 448 1.00 421 0.94 428 0.97 389 0.89
55–64 547 1.57 610 1.67 645 1.69 639 1.66 704 1.79
65–74 254 1.22 296 1.36 285 1.27 314 1.31 343 1.36
≥75 245 1.30 248 1.34 269 1.42 229 1.20 251 1.29
 
Race§ White 978 0.35                
Black 320 0.87                
Non-White, non-Black 399 2.15                
 
  Race/
Ethnicity
¶**
White, non-
Hispanic
    856 0.34 832 0.32 818 0.31 868 0.33
Black, non-
Hispanic
    356 0.94 373 0.98 322 0.81 384 0.98
Hispanic     136 0.43 161 0.48 139 0.39 149 0.39
Asian/Pacific
Islander
    421 2.95 422 2.72 469 2.93 451 2.64
American
Indian/Alaskan
Native
    17 0.73 9 0.38 18 0.74 14 0.55
 
Sex Male 1,267 0.80 1,316 0.81 1,321 0.80 1,272 0.75 1,375 0.79
Female 430 0.24 476 0.27 483 0.26 499 0.27 498 0.26
 
Overall
1,697 0.51 1,792 0.52 1,804 0.52 1,771 0.50 1,873 0.52

* Rates for race, sex, and overall total are age-adjusted per 100,000 U.S. standard population in 2000.
† Cause of death is defined as the underlying cause of death or one of the multiple causes of death and is based on the International Classification of Diseases, 10th Revision (ICD-10) codes B16, B17.0, B18.0, B18.1 (hepatitis B).
§ The race category "White" Included white, non-Hispanic and white Hispanic. The race category "Black" included black, non-Hispanic and black Hispanic. The race category "Non-White, non-Black" included all other races.
¶ The race/ethnicity category was added starting in 2010 to incorporate bridged race categories. Six deaths in 2010, seven deaths in 2011, five deaths in 2012, and seven deaths in 2013 are not represented under the race/ethnicity category due to missing race and/or ethnicity data.

Source: CDC. National Vital Statistics System.

Figure 3.1. Reported number of acute hepatitis B cases — United States, 2000-2013

Downloads of this slide: PDF    PowerPoint
Figure 3.2. Incidence of acute hepatitis B, by age group — United States, 2000-2013

Downloads of this slide: PDF    PowerPoint
Figure 3.3. Incidence of acute hepatitis B, by sex — United States, 2000-2013

Downloads of this slide: PDF    PowerPoint
Figure 3.4. Incidence of acute hepatitis B, by race/ethnicity — United States, 2000-2013

Downloads of this slide: PDF    PowerPoint
Figure 3.5. Availability of information on risk exposures/behaviors associated with acute hepatitis B — United States, 2013

Downloads of this slide: PDF    PowerPoint

Figure 3.6a. Acute hepatitis B reports, by risk exposure/behavior — United States, 2013

Downloads of this slide: PDF    PowerPoint
Figure 3.6b. Acute hepatitis B reports, by risk exposure/behavior — United States, 2013

Downloads of this slide: PDF    PowerPoint

All seven figure slides in PowerPoint 2007 format [PPTX – 369 KB]

Hepatitis C virus

PAGE
DESCRIPTION
Table 4.1 Reported cases of acute hepatitis C, nationally and by state ― United States, 2009-2013
Table 4.2 Clinical characteristics of reported cases of acute hepatitis C ― United States, 2013
Table 4.3 Number of newly reported past or present hepatitis C case-reports submitted by states, 2013
Table 4.4 Reported cases of past or present hepatitis C, by demographic characteristics and laboratory tests – Enhanced Viral Hepatitis Surveillance Sites, 2013
Table 4.5 Number and rate of hepatitis C-related deaths, by demographic characteristics and year – United States, 2009-2013
Slide 4.1 Reported number of acute hepatitis hepatitis C cases — United States, 2000-2013
Slide 4.2 Incidence of acute hepatitis C, by age group — United States, 2000-2013
Slide 4.3 Incidence of acute hepatitis C, by sex — United States, 2000-2013
Slide 4.4 Incidence of acute hepatitis C, by race/ethnicity — United States, 2000-2013
Slide 4.5 Availability of information on risk exposures/behaviors associated with acute hepatitis C — United States, 2013
Slide 4.6a Acute hepatitis C reports, by risk behavior — United States, 2013
Slide 4.6b Acute hepatitis C reports, by risk exposure — United States, 2013
  

Hepatitis C virus

Table 4.1 Reported cases of acute hepatitis C, nationally and by state ― United States, 2009-2013

State
2009
2010
2011
2012
2013
Rate* (No.) Rate (No.) Rate (No.) Rate (No.) Rate (No.)
Alabama
0.2
(10)
0.1
(7)
0.5
(23)
0.5
(24)
0.6 (30)
Alaska
U
U
U
U
U
U
U
U
U (U)
Arizona
U
U
U
U
U
U
U
U
U (U)
Arkansas
0.1
(2)
0
(1)
0
(0)
0.2
(5)
1.0 (30)
California
0.1
(43)
0.1
(32)
0.1
(48)
0.2
(63)
0.2 (72)
Colorado
0.6
(28)
0.4
(20)
0.5
(28)
0.8
(42)
0.4 (21)
Connecticut
1.5
(53)
1.0
(37)
1.3
(47)
0.9
(34)
U (U)
Delaware
U
U
U
U
U
U
U
U
0.0 (0)
District of Columbia
0.2
(1)
0.3
(2)
U
U
U
U
U (U)
Florida
0.3
(53)
0.3
(56)
0.3
(64)
0.6
(107)
0.7 (134)
Georgia
0.3
(31)
0.3
(32)
0.5
(53)
0.8
(82)
0.5 (48)
Hawaii
U
U
U
U
U
U
U
U
U (U)
Idaho
0.5
(7)
0.7
(11)
0.8
(12)
0.7
(11)
0.9 (14)
Illinois
0
(6)
0
(1)
0
(6)
0.2
(26)
0.3 (37)
Indiana
0.3
(22)
0.4
(27)
1.3
(84)
1.7
(110)
2.7 (175)
Iowa
0.4
(11)
0
0
0
(0)
0.1
(3)
U (U)
Kansas
0
(1)
0.1
(2)
0.3
(8)
0.6
(16)
0.6 (17)
Kentucky
1.5
(64)
2.5
(109)
3.2
(142)
4.1
(178)
5.1 (226)
Louisiana
0.2
(9)
0.1
(4)
0.2
(7)
0.2
(11)
0.4 (19)
Maine
0.2
(2)
0.2
(2)
0.9
(12)
0.6
(8)
0.6 (8)
Maryland
0.4
(23)
0.4
(24)
0.6
(35)
0.7
(39)
0.9 (53)
Massachusetts
0.2
(10)
0.2
(13)
0.3
(23)
0.6
(37)
2.6 (174)
Michigan
0.4
(35)
0.5
(45)
0.3
(32)
0.8
(76)
0.7 (74)
Minnesota
0.3
(15)
0.3
(16)
0.3
(17)
0.6
(32)
0.9 (47)
Mississippi
U
U
U
U
U
U
U
U
U (U)
Missouri
0
(0)
0.1
(6)
0.1
(8)
0.1
(4)
0.1 (6)
Montana
0.1
(1)
0.4
(4)
0.9
(9)
0.9
(9)
1.6 (16)
Nebraska
0.2
(3)
0.1
(2)
0.1
(2)
0.2
(3)
0.1 (2)
Nevada
0.2
(5)
0.3
(7)
0.4
(10)
0.4
(12)
0.3 (9)
New Hampshire
U
U
U
U
U
U
U
U
U (U)
New Jersey
0.1
(7)
0.3
(28)
0.6
(53)
0.8
(71)
1.2 (106)
New Mexico
0.3
(6)
0.7
(14)
0.7
(14)
1
(21)
0.6 (12)
New York
0.3
(53)
0.3
(50)
0.3
(52)
0.5
(93)
0.7 (131)
North Carolina
0.3
(24)
0.4
(39)
0.6
(60)
0.6
(63)
0.8 (79)
North Dakota
0.3
(2)
0
(0)
0
(0)
0
0
0.6 (4)
Ohio
0.2
(26)
0.1
(10)
0.1
(6)
0.1
(7)
1.0 (116)
Oklahoma
0.7
(27)
1.1
(41)
1.4
(53)
2.1
(80)
1.0 (40)
Oregon
0.5
(19)
0.5
(19)
0.5
(20)
0.9
(37)
0.4 (14)
Pennsylvania
0.3
(39)
0.2
(26)
0.3
(35)
0.5
(66)
0.6 (81)
Rhode Island
U
U
U
U
U
U
U
U
U (U)
South Carolina
0
(1)
0
(1)
0
(1)
0
(1)
0.0 (0)
South Dakota
U
U
U
U
U
U
U
U
0.0 (1)
Tennessee
0.5
(33)
0.7
(46)
1.3
(83)
2
(129)
1.5 (98)
Texas
0.1
(36)
0.1
(35)
0.1
(37)
0.2
(44)
0.1 (28)
Utah
0.2
(6)
0.4
(10)
0.4
(10)
0.6
(17)
0.4 (11)
Vermont
0.2
(1)
0.3
(2)
1.0
(6)
1
(6)
0.5 (3)
Virginia
0.1
(10)
0.2
(13)
0.3
(25)
0.9
(76)
0.5 (41)
Washington
0.3
(22)
0.4
(25)
0.6
(41)
0.8
(54)
0.9 (63)
West Virginia
1.7
(31)
1.1
(21)
2.5
(46)
3
(55)
3.1 (58)
Wisconsin
0.1
(3)
0.2
(10)
0.3
(15)
0.5
(26)
0.7 (40)
Wyoming
0
(0)
0
(0)
0.4
(2)
U
U
U (U)
Total
0.3
(781)
0.3
(850)
0.4
(1,229)
0.6
(1,778)
0.7 (2,138)

*Rate per 100,000 population. 
U=No data available for reporting.
Source: CDC, National Notifiable Diseases Surveillance System.

Table 4.2 Clinical characteristics of reported cases of acute hepatitis C ― United States, 2013

Clinical characteristic
Availability of valid data† for clinical characteristic
Cases with clinical characteristic§
No.
%
No.
%
Jaundice
1,491 69.7 963 64.6
Hospitalized for hepatitis C
1,382 64.6 794 57.5
Died from hepatitis C
1,291 60.4 3 0.2

*A total of 2,138 hepatitis C cases were reported during 2013.
†Case reports for which questions regarding clinical characteristics were answered with “yes” or “no.” Reports with any other response were excluded.
§Numbers and percentages represent only those case reports for which data regarding clinical characteristics were available; numbers likely are underestimates.
Source: CDC, National Notifiable Diseases Surveillance System.

Table 4.3 Number of newly reported past or present hepatitis C case-reports submitted by states, 2013

Jurisdiction No. chronic hepatitis C
case reports submitted
Data Source
Colorado 2,982 State-provided
Connecticut¶ 2,749 State-provided
Florida¶ 19,759 NNDSS
Kansas 1,532 State-provided
Maine** 1,265 State-provided
Michigan¶ 6,719 State-provided
Minnesota** 1,601 NNDSS
Montana¶ 1,141 State-provided
New Jersey** 6,580 NNDSS
New Mexico 959 State-provided
New York
(minus New York City)**
6,633 State-provided
New York City** 6,822 State-provided
Oregon** 3,772 State-provided
Pennsylvania¶ 8,882 State-provided
South Carolina†† 3,238 NNDSS
South Dakota** 405 NNDSS
West Virginia** 4,503 State-provided
Total
79,542
 

Abbreviation: NNDSS, National Notifiable Diseases Surveillance System
* For case-definition, see http://wwwn.cdc.gov/nndss/script/ConditionList.aspx?Type=0&Yr=2012.
† Reports may not reflect unique cases. §Jurisdictions that gave permission to report their number of chronic HBV cases
¶ Includes confirmed and probable case reports only.
** Includes confirmed case reports only.
†† Includes confirmed, probable, and suspect case reports.

Table 4.4. Reported cases of past or present hepatitis C, by demographic characteristics and laboratory tests – Enhanced Viral Hepatitis Surveillance Sites, 2013

Category Massa-
chusetts
No. (%)
Michigan
No. (%)
New York
State†
No. (%)
Philadel-
phia
No. (%)
San Francisco
No. (%)
Washing-
ton§
No. (%)
Total
No. (%)
Sex
Female 2,013
39.1%
2,188
35.4%
2,430
36.6%
457
35.9%
389
30.3%
1,119
41.0%
8,596
37.0%
Male 3,116
60.6%
3,976
64.3%
4,172
62.9%
813
63.9%
879
68.6%
1,534
56.2%
14,490
62.3%
Unknown/
missing
17
0.3%
17
0.3%
31
0.5%
3
0.2%
14
1.1%
76
2.8%
158
0.7%
Race/ethnicity
American Indian/
Alaskan Native,
non-Hispanic (NH)
20
0.4%
66
1.1%
23
0.3%
1
0.1%
16
1.2%
121
4.4%
247
1.1%
Asian/Pacific
Islander,  NH
86
1.7%
22
0.4%
72
1.1%
22
1.7%
60
4.7%
23
0.8%
285
1.2%
Black,  NH 208
4.0%
1,228
19.9%
578
8.7%
341
26.8%
230
17.9%
35
1.3%
2,620
11.3%
White,  NH 2,492
48.4%
2,923
47.3%
2,851
43.0%
219
17.2%
455
35.5%
712
26.1%
9,652
41.5%
Hispanic 347
6.7%
85
1.4%
430
6.5%
86
6.8%
96
7.5%
72
2.6%
1,116
4.8%
Other,  NH 115
2.2%
78
1.3%
88
1.3%
7
0.5%
14
1.1%
18
0.7%
320
1.4%
Unknown/
missing
1,878
36.5%
1,779
28.8%
2,591
39.2%
597
46.9%
411
32.1%
1,748
64.1%
9,004
38.7%
Age group, years
0-14 41
0.8%
36
0.6%
13
0.2%
9
0.7%
0
0.0%
8
0.3%
107
0.5%
15-24 798
15.5%
567
9.2%
724
10.9%
78
6.1%
32
2.5%
249
9.1%
2,448
10.5%
25-39 1,762
34.2%
1,285
20.8%
1,815
27.4%
238
18.7%
209
16.3%
609
22.3%
5,918
25.5%
40-54 1,353
26.3%
1,611
26.1%
1,809
27.3%
411
32.3%
437
34.1%
969
35.5%
6,590
28.4%
55+ 1,192
23.2%
2,682
43.4%
2,260
34.1%
537
42.2%
597
46.6%
891
32.6%
8,159
35.1%
Unknown/
missing
0
0.0%
0
0.0%
12
0.2%
0
0.0%
7
0.5%
3
0.1%
22
0.1%
Hepatitis C laboratory testing¶
Anti-HCV+ 4,145
80.5%
2,367
38.3%
5,165
77.9%
890
69.9%
896
69.9%
1,640
60.1%
15,103
65.0%
HCV RNA + 3,820
74.2%
1,402
22.7%
5,575
84.0%
1,120
88.0%
780
60.8%
1,476
54.1%
14,173
61.0%
Total no. cases  5,146 6,181 6,633 1,273 1,282 2,729 23,244
2013 Estimated
population total**
6,692,824 9,895,622 11,245,290 1,553,165 837,442 5,405,750 35,630,093
Rate per 100,000
population
76.9 62.5 59.0 82.0 153.1 50.5 65.2

* Past or present hepatitis C data from Florida, one of the 7 funded sites, were not included in this table.  Past or present hepatitis C data from all funded sites, including Florida, will be published in an updated table in July.
† Cases and population estimates from New York excluded those who resided in New York City.
§ Cases from Washington excluded Snohomish County, Pierce County, and 90% of King County.
¶ Cases can be reported with more than one laboratory test result. The denominator used to calculate proportions was the total number of cases reported for each site.
** Population estimates for the United States: https://wonder.cdc.gov/bridged-race-population.html. Population estimates from Washington excluded Snohomish and Pierce Counties.

Table 4.5. Number and rate of hepatitis C-related deaths, by demographic characteristics and year – United States, 2009-2013

Demographic characteristic
2009
2010
2011
2012
2013
No. Rate No. Rate No. Rate No. Rate No. Rate
  Age Group
(years)
0–34 116 0.08 117 0.08 128 0.09 158 0.11 121 0.08
35–44 828 1.99 712 1.73 696 1.71 622 1.54 573 1.42
45–54 5,469 12.26 5,171 11.49 5,073 11.34 4,749 10.73 4,344 9.93
55–64 6,683 19.21 7,431 20.37 8,330 21.89 9,235 23.93 9,899 25.18
65–74 1,824 8.77 1,901 8.75 2,136 9.5 2,515 10.49 3,004 11.91
≥75 1,333 7.01 1,293 6.97 1,357 7.18 1,369 7.15 1,425 7.31
 
Race White§ 12,682 4.43                
Black 2,908 7.80                
Non-White, non-Black** 663 3.61                
 
  Race/
Ethnicity
White, non-
Hispanic
 
    10,575 4.03 11,196 4.19 11,839 4.35 12,219 4.40
Black, non-
Hispanic
    2,981 7.72 3,167 7.89 3,232 7.81 3,520 8.35
Hispanic     2,318 6.83 2,555 7.15 2,668 7.19 2,699 6.91
Asian/ Pacific
Islander
    440 3.30 455 3.14 472 3.15 495 3.09
American
Indian/ Alaskan
Native
    248 9.90 275 10.61 313 11.81 324 12.22
 
Sex Male 11,517 6.91 11,781 6.81 12,651 7.11 13,300 7.31 13,745 7.40
Female 4,736 2.65 4,846 2.63 5,070 2.7 5,350 2.77 5,623 2.85
 
Overall
16,235 4.70 16,627 4.65 17,721 4.82 18,650 4.96 19,368 5.03

* Rates for race, sex, and overall total are age-adjusted per 100,000 U.S. standard population in 2000.
† Cause of death is defined as the underlying cause of death or one of the multiple causes of death and is based on the International Classification of Diseases, 10th Revision (ICD-10) codes B17.1, and B18.2 (hepatitis C).
§ Two deaths in 2010, one death in 2011, two deaths in 2012, and two deaths in 2013 are not represented under the age category due to missing age data.
¶ The race category "White" Included white, non-Hispanic and white Hispanic. The race category "Black" included black, non-Hispanic and black Hispanic. The race category "Non-White, non-Black" included all other races.
** The race/ethnicity category was added starting in 2010 to incorporate bridged race categories. 65 deaths in 2010, 73 deaths in 2011, 126 deaths in 2012, and 111 deaths in 2013 are not represented under the race/ethnicity category due to missing race and/or ethnicity data.

Source: CDC. National Vital Statistics System.

Figure 4.1. Reported number of acute hepatitis C cases — United States, 2000-2013

Downloads of this slide: PDF    PowerPoint
Figure 4.2. Incidence of acute hepatitis C, by age group — United States, 2000-2013

Downloads of this slide: PDF    PowerPoint
Figure 4.3. Incidence of acute hepatitis C, by sex — United States, 2000-2013

Downloads of this slide: PDF    PowerPoint
Figure 4.4. Incidence of acute hepatitis C, by race/ethnicity — United States, 2000-2013

Downloads of this slide: PDF    PowerPoint
Figure 4.5. Availability of information on risk exposures/behaviors associated with acute hepatitis C — United States, 2013

Downloads of this slide: PDF    PowerPoint
Figure 4.6a. Acute hepatitis C reports, by risk exposure/behavior — United States, 2013

Downloads of this slide: PDF    PowerPoint
Figure 4.6b. Acute hepatitis C reports, by risk exposure/behavior — United States, 2013

Downloads of this slide: PDF    PowerPoint

All seven figure slides in PowerPoint 2007 format [PPTX – 368 KB]

 

TOP